Literature DB >> 22565652

Nasal septal deviation in a mediaeval population.

Simon Mays1.   

Abstract

In modern populations, there is evidence that nasal septal deviation (NSD) may be associated with maxillary sinusitis, and that those with NSD may differ in craniofacial morphology from those without or with less severe NSD. Whether these associations hold true for earlier populations has yet to be investigated. The current work is a step toward remedying this. The study group comes from a mediaeval English archaeological site. NSD was quantified using image analysis. Maxillary sinusitis was identified from new bone formation in the antrum. Cranial morphology was assessed using standard craniometric measurements. The results provided no evidence for a relationship between NSD and maxillary sinus disease. NSD was associated with reduced measures of upper facial height, suggesting decoupling of growth in vertical height of the nasal septum and the bony structures surrounding it.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22565652     DOI: 10.1002/ajpa.22046

Source DB:  PubMed          Journal:  Am J Phys Anthropol        ISSN: 0002-9483            Impact factor:   2.868


  3 in total

1.  Morphological interaction between the nasal septum and nasofacial skeleton during human ontogeny.

Authors:  Matthew J Goergen; Nathan E Holton; Thorsten Grünheid
Journal:  J Anat       Date:  2017-02-20       Impact factor: 2.610

2.  Prevalence of Nasal Septum Deviation Using Cone-Beam Computed Tomography: A Cross-Sectional Study.

Authors:  Mahkameh Moshfeghi; Bahareh Abedian; Mitra Ghazizadeh Ahsaie; Farzam Tajdini
Journal:  Contemp Clin Dent       Date:  2020-11-26

3.  Decreased hospital charges and postoperative pain in septoplasty by application of enhanced recovery after surgery.

Authors:  Zhenpeng Liao; Wei Liao; Kai Sen Tan; Yueqi Sun; Aiqing Peng; Yingxian Zhu; Haixin He; Shuowei Yang; Guangfu Xu; Rongfei Su; Jinyu Yao; Yunping Fan; Qintai Yang; Haiyu Hong
Journal:  Ther Clin Risk Manag       Date:  2018-10-04       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.